ISMP Survey on Internal and External Medication Error Reporting

(Survey data collected November-December, 2002, and based on respondent's experiences during the year 2002)

Click here to view article "The reports are in...or are they? Awareness of medication error reporting programs needs a boost "

Table 1. Respondent Profile (N=319)

Profession

Percent of Respondents

Level

Percent of Respondents

Nurse

32%

Administration

16%

Pharmacist

64%

Middle Manager

48%

Physician

3%

Staff Level

36%

Pharmacy technician

1%

Other

<1%

Table 2. Percent of Respondents Who Reported 0, 1-5, or >5 Medication Errors/Patient Safety Issues

Type of Error or Other Medication Safety Issue

Internal System-Wide Reporting

External

Reporting

 

Program

ISMP/USP Reporting Program

FDA MEDWATCH

 

0 | 1-5 | >5

0 | 1-5 | >5

0 | 1-5 | >5

a. Adverse drug reaction

25 | 31 | 44

82 | 15 | 03

57 | 36 | 07

b. A hazardous condition that could lead to error

25 | 44 | 31

80 | 18 | 02

88 | 11 | 01

c. An error that did not reach the patient

20 | 33 | 47

88 | 10 | 02

95 | 04 | 00

d. Error that reached a patient but caused no harm

21 | 34 | 44

88 | 11 | 02

93 | 06 | 00

e. Error that caused patient harm

50 | 35 | 15

88 | 10 | 02

86 | 14 | 01


Table 3: Percent of Respondents Who Felt Motivational Factors Stimulated Reporting

Motivational Factors

Internal System-Wide Reporting

External

Reporting

 

Program

ISMP/USP Reporting Program

FDA MEDWATCH

 

Yes | No

Yes | No

Yes | No

a. My superior mandates that I report

71 | 29

25 | 75

30 | 70

b. I'm granted amnesty if I report an error

49 | 51

38 | 62

40 | 60

c. I feel rewarded for reporting

53 | 47

58 | 42

49 | 51

d. The information is used to enhance safety

95 | 05

90 | 10

89 | 11

e. I want others to know about the problem so needless tragedies can be prevented

98 | 02

91 | 09

50 | 50

f. The reporting program is easy to use

72 | 28

67 | 33

61 | 39

g. I trust that my name will be kept confidential

65 | 35

77 | 23

71 | 29


Table 4. Percent of Respondents Who Witnessed People, Organizations, or Others Promote Reporting
(Key: F = Frequently; S = Sometimes; N = Never)

People, Organizations, and Other Healthcare Stakeholders

Internal System-Wide Reporting

External

Reporting

 

Program

ISMP/USP Reporting Program

FDA MEDWATCH

 

F | S | N

F | S | N

F | S | N

a. Trustees/Senior Leaders

30 | 39 | 31

17 | 20 | 63

11 | 26 | 63

b. Middle Managers

47 | 42 | 11

14 | 28 | 57

11 | 29 | 60

c. Risk Manager

60 | 22 | 18

20 | 22 | 58

16 | 25 | 60

d. Quality Improvement Professional

60 | 21 | 18

18 | 27 | 55

16 | 24 | 60

e. Patient/Medication Safety Officer

57 | 20 | 22

20 | 27 | 53

16 | 29 | 55

f. Staff Educators

39 | 33 | 27

11 | 18 | 71

08 | 20 | 72

g. Professional Licensing Bodies

30 | 33 | 37

16 | 28 | 56

16 | 28 | 56

h. Professional Organizations

50 | 28 | 22

39 | 29 | 32

35 | 30 | 35

i. Professional Journals/Newsletters

58 | 26 | 16

39 | 27 | 35

36 |36 | 28

j. Local/Federal Government

22 | 35 | 43

10 | 29 | 61

10 | 32 | 58

k. Accrediting Bodies (e.g., JC)

62 | 20 | 18

34 | 28 | 38

35 | 26 | 39

l. Academic Educators

20 | 34 | 46

13| 18 | 69

13 | 21 | 67

m. Drug/Medical Product Vendors

10| 35 | 55

06 | 21 | 72

09 | 22 | 70

 

Copyright © <%= year(date) %>, ISMP. All rights reserved